Local 12: Diabetes study focuses on how long blood sugar control can be maintained
The University of Cincinnati's Robert Cohen, MD, spoke with Local 12 about the GRADE study.
"This was a type two diabetes study, and whereas most studies are looking at how good the blood sugar control can be, this study was focused on how long the blood sugar control can be maintained,” said Cohen, a professor in UC's College of Medicine and UC Health endocrinologist.
Maintaining blood sugar control near normal levels can lower the risk of further complications like heart and kidney disease and vision problems for people with diabetes, Cohen said.
The years-long study found medications now known as Ozempic or Mounjaro were some of the best at maintaining long-term blood sugar control.
“That and insulin itself really did the best job of preserving glycemic blood sugar control,” Cohen said.
As the research continues, Cohen said the team will move beyond drugs that bring down blood sugar levels to evaluate drugs that preserve insulin-producing cells.
Watch or read the Local 12 story.
Featured photo at top of a semaglutide injection pen. Photo/aprott/iStock.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.